4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-21-046029
President and CEO gave up 10 shares (to pay taxes)
- President and CEO acquired 35 shares (option exercise)
- President and CEO acquired 123 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph President and CEO | 2021-07-06 | Conversion | +123 | 1,542 | D | ||
| OConnell Daniel Joseph President and CEO | 2021-07-06 | Option exercise | +35 | $4.47 | $156 | 1,577 | D |
| OConnell Daniel Joseph President and CEO | 2021-07-06 | Shares withheld for taxes | −10 | $16.00 | $160 | 1,567 | D |
| Derivatives | |||||||
| OConnell Daniel Joseph President and CEO | 2021-07-06 | Conversion · Series A Preferred Stock | −123 | 0 | D | ||
| OConnell Daniel Joseph President and CEO | 2021-07-06 | Option exercise · Warrant (Right to Buy) | −35 | 0 | D | ||
Loading xslF345X03/doc4.xml…